NEW YORK (GenomeWeb News) – Rutgers University and Carestream Molecular Imaging today announced the signing of a two-year collaborative agreement that provides the university with a PET/CT imaging platform, computer systems, and software.
As part of the deal, Rutgers and Carestream will partner on product awareness, the exchange of scientific knowledge, and new product development. The new Molecular Imaging Center at the university will also serve as a user demonstration site.
The deal includes the placement of Carestream's Albira PET/CT system to the center. In addition to having both PET and CT modalities, the system can be upgraded to a third modality, single-photon emission computed tomography, or SPECT.
Financial and other terms of the agreement were not disclosed.
Based in Woodbridge, Conn., Carestream Molecular Imaging is a division of Carestream and provides molecular imaging systems for the life science research and drug discovery and development markets; dental and medical imaging systems and healthcare IT solutions; and X-ray film and digital X-ray products for the non-destructive testing space.